Orbis Investment Management Ltd - Sep 30, 2025 SCHEDULE 13G Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager: ORBIS INVESTMENT MANAGEMENT LTD
Reporting Manager: ORBIS INVESTMENT MANAGEMENT LTD
Security: CRISPR Therapeutics AG Common Stock
Symbol: CRSP
Shares outstanding: 90.4M shares
Disclosed Ownership: 4.97M shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Date filed: 11/14/2025, 12:26 PM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIS INVESTMENT MANAGEMENT LTD	5.5%	4.97M	4.97M	0	Matthew Gaarder	Attorney-in-Fact
Allan Gray Australia Pty Ltd	0%	7.96K	7.96K	0	Matthew Gaarder	Attorney-in-Fact